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Abstract
Intestinal bacterial dysbiosis is evident in children with cystic fibrosis (CF) and intestinal
viruses may be contributory, given their influence on bacterial species diversity and bio-
chemical cycles. We performed a prospective, case-control study on children with CF and
age and gender matched healthy controls (HC), to investigate the composition and function
of intestinal viral communities. Stool samples were enriched for viral DNA and RNA by viral
extraction, random amplification and purification before sequencing (Illumina MiSeq). Taxo-
nomic assignment of viruses was performed using Vipie. Functional annotation was per-
formed using Virsorter. Inflammation was measured by calprotectin and M2-pyruvate
kinase (M2-PK). Eight CF and eight HC subjects were included (50% male, mean age 6.9 ±
3.0 and 6.4 ± 5.3 years, respectively, p = 0.8). All CF subjects were pancreatic insufficient.
Regarding the intestinal virome, no difference in Shannon index between CF and HC was
identified. Taxonomy-based beta-diversity (presence-absence Bray-Curtis dissimilarity)
was significantly different between CF and HC (R2 = 0.12, p = 0.001). Myoviridae, Faecali-
bacterium phage FP Taranis and unclassified Gokushovirinae were significantly decreased
in CF compared with HC (q<0.05). In children with CF (compared to HC), the relative abun-
dance of genes annotated to (i) a peptidoglycan-binding domain of the peptidoglycan hydro-
lases (COG3409) was significantly increased (q<0.05) and (ii) capsid protein (F protein)
(PF02305.16) was significantly decreased (q<0.05). Picornavirales, Picornaviridae, and
Enterovirus were found to positively correlate with weight and BMI (r = 0.84, q = 0.01). Sin-
gle-stranded DNA viruses negatively correlated with M2-PK (r = -0.86, q = 0.048). Children
with CF have an altered intestinal virome compared to well-matched HC, with both taxo-
nomic and predicted functional changes. Further exploration of Faecalibacterium phages,
Gokushovirinae and phage lysins are warranted. Intestinal viruses and their functions may
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have important clinical implications for intestinal inflammation and growth in children with
CF, potentially providing novel therapeutic targets.
Introduction
Dysfunction of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) results
in an altered intestinal milieu with proposed mechanisms including: (i) reduced bicarbonate
secretion and low intestinal pH, (ii) thick and inspissated mucus, (iii) a lack of endogenous
pancreatic enzymes, (iv) delayed intestinal transit and (v) possibly impaired innate immunity
[1, 2]. These mechanisms along with treatment and diet regimens [3] likely result in intestinal
bacterial dysbiosis and inflammation, which have repeatedly been reported in CF [4–12].
Intestinal inflammation in CF may have significant clinical relevance due to its link with
growth and nutrition [9, 13, 14]. In children with CF compared to healthy controls (HC),
intestinal bacterial profiles are often characterised by an increased abundance of Proteobac-
teria (Escherichia coli, Shigella, Enterobacter) and a decreased abundance of Bacteroidetes (Bac-
teroides, Alistipes) and Firmicutes (Faecalibacterium prausnitzii) [4, 6, 8, 12]. It has been
suggested that in children with CF, enteric fat abundance (increased as a result of diet regi-
mens and a lack of endogenous pancreatic enzymes) selects for pro-inflammatory gut micro-
biota [6]. Additionally, the faecal microbiota of people with CF may have a higher prevalence
of amoxicillin resistance [15].
Intestinal viruses also have the potential to contribute to bacterial dysbiosis and intestinal
inflammation, given their influence on bacterial species diversity and biochemical cycles. To
the best of our knowledge, the intestinal virome has yet to be explored in CF, both in terms of
characterisation and its potential contribution to microbiota, inflammation and CF
pathogenesis.
Human faecal viromes typically consist of eukaryote-infecting viruses, and bacteriophages
(viruses of bacterial hosts). Predominant bacteriophages in the gut include double-strand
DNA (dsDNA) Caudovirales and single-strand DNA (ssDNA) Microviridae [16–19]. The
community of intestinal bacteriophages show substantial inter-individual variability, but
appear temporally stable within a single individual [16, 17]. Bacteriophages can influence bac-
terial populations via host lysis and horizontal gene transfer, as well as playing an indirect role
in regulating immune function and inflammation [19–22]. Specifically, inflammatory bowel
disease studies have shown changes in the intestinal virome (compared to HC) are likely due
to changes in lytic phage populations, which lyse bacterial hosts, resulting in release of patho-
gen-associated molecular patterns and antigens that cause inflammation [19, 23].
In recent years there has been a focus on the role of viruses in CF lung disease [24]. In CF
airways, environmental stress and frequent antibiotic treatment has been suggested to enhance
bacteriophage mobility and promote bacteriophage-mediated spread of antibiotic resistance
genes [25, 26]. The respiratory viromes of adults with CF have previously been explored in sev-
eral small studies using a metagenomics approach, [27–30] however only Willner et al. (2009)
[27] included healthy controls in their study. To the best of our knowledge, the intestinal vir-
ome in CF has not been explored, particularly in comparison to matched-healthy controls.
The aim of this study was to investigate the composition and function of viral communities
inhabiting the intestines of children with CF. We hypothesized that the composition and func-
tional capacity of viral communities in the intestines of children with CF are different when
compared to HC. Furthermore, we hypothesized that these alterations have clinical implica-
tions in children with CF.
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Results
Population characteristics
There were eight children with CF and eight paired HC matched for age and gender included
in this study. The mean age of CF and HC subjects was 6.9 ± 3.0 and 6.4 ± 3.2 years, respec-
tively (p = 0.8), with a range of 3 to 12 years for both cohorts. Each group consisted of four
males (50%). All CF children were pancreatic insufficient (PI) and five were homozygous for
the F508del mutation in the CFTR gene (a disease-causing CF mutation) (63%), whilst the
remaining three were heterozygous for the F508del mutation and a second disease-causing
mutation (37%). No CF participants were on CFTR modulator therapy. Clinical characteristics
are presented in Table 1.
Virome characteristics
Viral community structures were successfully assessed using Illumina MiSeq sequencing of a
viral DNA and RNA enrichment of stool samples. Sequencing data were processed using the
Vipie pipeline and contained an average of 3,909,006 ± 1,283,246 reads per sample, which after
quality filtering and de novo assembly resulted in a median (IQR; range) of 863 (625–2946;
227–7737) contigs per sample. On average, samples contained 568,964 ± 201,042 reads that
were mapped to viruses (75.6% ± 27.5%), bacterial ribosomes (23.7% ± 27.2%) and humans
(0.63% ± 0.88%) (S3 Data). Bacterial contamination rates (based on reads mapping to bacterial
ribosomes) ranged from 0.1% to 82.2% and both bacterial and human reads were filtered out
from the analysis. Rarefaction curves of viral taxa suggest the number of samples included in
this study did not reach virome saturation, suggesting that a larger number of samples per
cohort would be needed to capture the entire human virome (S1A and S1B Fig). However, sat-
uration of rarefaction curves for individual samples was achieved, suggesting that all viruses in
a given sample were recovered (S1C and S1D Fig).
Table 1. Clinical characteristics.
ID Gender Group Pancreas Age (years) Genotype Calprotectin(mg/kg) M2-PK (U/ml)
CF1 M CF PI 3.0 F508del / F508del 204.7 142.5
HC1 M HC HC 3.0 - / - - -
CF2 M CF PI 3.1 F508del / F508del 56.8 35.0
HC2 M HC HC 3.2 - / - 17.6 < 1
CF3 F CF PI 5.8 F508del / F508del 171.4 6.1
HC3 F HC HC 3.1 - / - 97.3 < 1
CF4 F CF PI 6.5 F508del / G551D 45.2 7.4
HC4 F HC HC 5.8 - / - 30.5 < 1
CF5 M CF PI 8.2 F508del / F508del 51.7 10.1
HC5 M HC HC 8.6 - / - - -
CF6 M CF PI 8.4 F508del / 394delTT 141.1 5.2
HC6 M HC HC 11.7 - / - < 19.5 3.0
CF7 F CF PI 8.8 F508del / F508del < 19.5 6.4
HC7 F HC HC 7.6 - / - - -
CF8 F CF PI 11.8 F508del / G551D 149.2 -
HC8 F HC HC 8.5 - / - < 19.5 < 1
Demographics and fecal inflammatory marker results of participants. No CF participants were on CFTR modulator therapy. M2-PK, M2-pyruvate kinase; PI, pancreatic
insufficient; -, not tested or data not available.
https://doi.org/10.1371/journal.pone.0233557.t001
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Alpha diversity of virome
Regarding the virome alpha diversity, children with CF and HC had no significant difference
in richness (number of unique viruses) (mean difference (95% CI) of -4.7 (-24.9 to 15.6),
p = 0.6) and Shannon index (mean difference (95% CI) of -0.3 (-1.4 to 0.9), p = 0.6) (Fig 1A
and 1B). Controlling for age, there was also no difference between children with CF and HC
for richness (estimate (SE) -4.1 (7.4), p = 0.6) and Shannon index (estimate (SE) -0.2 (0.5),
p = 0.6). However, with advancing age, alpha diversity indices (richness and Shannon index)
decreased in CF and increased in HC cohorts (Fig 1C and 1D). The intercepts for the two gen-
eralised linear models that fit the trends were significantly different (richness model p = 0.008;
Shannon index model p = 0.045) suggesting the effect of age should be considered.
Beta diversity of virome
Visualization of taxonomy-based beta diversity (Fig 2) showed a significant difference in viral
communities between CF and HC cohorts based on presence-absence data using Bray-Curtis
dissimilarity (BC) (R2 = 0.12, p = 0.001), but not on relative abundance data using BC (R2 =
0.08, p = 0.2). PERMANOVA showed no significant difference in viral communities between
males and females (relative abundance BC R2 = 0.09, p = 0.09; presence-absence BC R2 = 0.07,
p = 0.2). PERMANOVA showed a significant difference in viral communities across ages (rela-
tive abundance BC R2 = 0.11, p = 0.02; presence-absence BC R2 = 0.09, p = 0.04).
Differences in viral communities between CF and HC populations
The relative abundance of all viruses at each of the taxonomic ranks in CF and HC subjects are
presented in S2A–S2E Fig. Relative abundances of the top 20 most abundant viral genera in
Fig 1. Boxplots of sample richness (number of unique viruses) (A) and Shannon index (B) in CF and HC cohorts. Scatterplots of sample richness
(number of unique viruses) (C) and Shannon index (D) against age in CF and HC cohorts. Cohort mean and 95% confidence intervals are constructed
from generalised linear models and presented as lines and shaded regions, respectively (C, D).
https://doi.org/10.1371/journal.pone.0233557.g001
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CF and HC are presented in Fig 3. The relative abundance of Myoviridae (family) and one of
its species, Faecalibacterium phage FP Taranis were significantly decreased in children with
CF compared with HC (q<0.05) (S3A and S3C Fig). Unclassified Gokushovirinae was also sig-
nificantly decreased in children with CF compared with HC (q<0.05) (S3B Fig). Unclassified
Gokushovirinae consisted of two species of Gokushovirus (WZ-2015a and human gut gokusho-
virus isolate SH).
Fig 2. NMDS plots based on Bray-Curtis dissimilarities using relative abundance (A) and presence-absence (B) data between CF and HC cohorts.
https://doi.org/10.1371/journal.pone.0233557.g002
Fig 3. Relative abundance of top 20 most abundant viral genera for CF and HC subjects. Samples ordered in
increasing age (from left to right).
https://doi.org/10.1371/journal.pone.0233557.g003
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Porcine circovirus (PCV) and porcine parvovirus (PPV) are known to be in porcine-
derived pancreatic enzyme replacement therapy (PERT) products prescribed to patients with
CF [31, 32]. We identified PCV type 2 (PCV2) and PPV in 4/8 (50%) and 3/8 (38%) of CF sub-
jects respectively, and not in any HC subjects.
Functional annotations
The functional annotations were performed using Virsorter [33] to search against the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [34], Clusters of Orthologous Groups (COG)
[35] and Pfam [36] databases. On average, 225 (138) predictions were identified per sample.
Predictions were mapped to: (i) 71 unique KEGG terms (4.8% predictions mapped); (ii) 146
unique COG terms (10.4% predictions mapped); and (iii) 223 unique Pfam terms (16.6% pre-
dictions mapped). Visualization of beta diversity based on the functional annotation (Fig 4)
showed a significant difference in KEGG terms between CF and HC cohorts based on relative
abundance data using BC dissimilarity (R2 = 0.11, p = 0.04) and presence-absence data using
BC dissimilarity (R2 = 0.12, p = 0.04). There was no significant difference in COG terms
between CF and HC cohorts based on relative abundance BC (R2 = 0.08, p = 0.2) and pres-
ence-absence BC (R2 = 0.08, p = 0.3). There was a significant difference in Pfam terms between
CF and HC cohorts based on relative abundance BC (R2 = 0.14, p = 0.005), but not on pres-
ence-absence BC (R2 = 0.10, p = 0.07).
The relative abundance of peptidoglycan-binding (PGRP) domain of the peptidoglycan
hydrolases (COG3409 [COG]) was significantly elevated in children with CF compared with
HC (q<0.05) (S4A Fig). The relative abundance of capsid protein (F protein) (PF02305.16
[Pfam]) was significantly decreased in children with CF compared with HC (q<0.05) (S4B
Fig). There was no significant difference in the relative abundance of any KEGG terms
Fig 4. NMDS plots based on Bray-Curtis dissimilarities using relative abundance (A-C; top row) and presence-absence (D-F; bottom row) data on
functional annotation (using KEGG, COG and Pfam databases) between CF and HC cohorts.
https://doi.org/10.1371/journal.pone.0233557.g004
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between CF and HC cohorts (q<0.05), however zinc D-Ala-D-Ala carboxypeptidase (K08640
[KEGG]) came close to significance (q<0.1) (S4C Fig).
Age-related changes in the intestinal virome
Exploring the effect of age, linear models of the differentially abundant viruses and protein
sequences were constructed and presented in S5 Fig. Comparing children with CF and HC
whilst controlling for age, the relative abundance of: (i) Myoviridae was significantly decreased
with age in CF (estimate (SE) -1.1×10−4 (3.7×10−5), p = 0.01); (ii) unclassified Gokushovirinae
was not significantly different (estimate (SE) -0.02 (0.01), p = 0.2); (iii) Faecalibacterium phage
FP Taranis was significantly decreased in CF (estimate (SE) -4.5×10−5 (1.6×10−5), p = 0.02);
(iv) a peptidoglycan-binding (PGRP) domain of peptidoglycan hydrolases (COG3409) was sig-
nificantly increased in CF (estimate (SE) 2.0×10−3 (4.5×10−4), p = 0.0006); (v) capsid protein
(F protein) (PF02305.16) was significantly decreased in CF (estimate (SE) -0.008 (0.002),
p = 0.003); and (vi) zinc D-Ala-D-Ala carboxypeptidase (K08640) was significantly decreased
in CF (estimate (SE) -0.005 (0.001), p = 0.009) and significantly increased with age in HC (esti-
mate (SE) 0.0007 (0.0003), p = 0.02);
Associations with anthropometrics and inflammatory biomarkers in
children with CF
In children with CF, there were no significant correlations between alpha diversity indices
(richness and Shannon diversity index) and anthropometric (height, weight and body mass
index (BMI)) z-scores or intestinal inflammatory makers (calprotectin and M2-PK). Correla-
tions between the relative abundances of viruses with anthropometric z-scores and intestinal
inflammatory makers in children with CF are presented in S1 Table. Picornavirales, Picorna-
viridae and Enterovirus positively correlated with weight and BMI (r = 0.84, q = 0.01). Anello-
viridae also positively correlated with weight and BMI (r = 0.79, q = 0.03). Parvoviridae and
Protoparvovirus negatively correlated with weight (r = -0.87, q = 0.03).
Regarding inflammatory markers, children with CF had significantly elevated median
(IQR) faecal calprotectin levels compared to HC (98.9 mg/kg (50.1–104.9) vs. 19.5 mg/kg
(19.5–30.5), respectively, p = 0.047; lower limit of detection was 19.5 mg/kg) (S6A Fig). Median
(IQR) faecal M2-PK levels were also significantly elevated in CF compared with HC (7.4 U/ml
(6.3–22.6) vs. 1.0 U/ml (1.0–1.0), respectively, p = 0.005; lower limit of detection was 1.0 U/ml)
(S6B Fig). Podoviridae positively correlated with M2-PK (r = 0.85, q = 0.03). Single-stranded
DNA viruses and unclassified ssDNA viruses (order) negatively correlated with M2-PK (r =
-0.86, q = 0.048).
Correlations between the relative abundances of KEGG, COG and Pfam terms with anthro-
pometric z-scores and intestinal inflammatory makers in children with CF are presented in S2
Table. N-acetylmuramoyl-L-alanine amidase (K01447) positively correlated with height
(r = 0.85, q = 0.02). No correlations with q<0.05 were identified between COG or Pfam terms
and: (i) anthropometric z-scores, or (ii) intestinal inflammatory markers.
Discussion
We have demonstrated the intestines of children with CF exhibit an altered intestinal virome,
which includes both taxonomic and functional changes, when compared to matched healthy
controls. To our knowledge, this is the first study to explore the intestinal virome in children
with CF using a metagenomics approach on an enriched virome preparation. We observed
high inter-individual variability in intestinal viruses and distinct clustering (based on pres-
ence-absence data for the BC analysis) between CF and HC cohorts. The results of this study
PLOS ONE The intestinal virome in children with cystic fibrosis and controls
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suggest that the virome has a potential role in intestinal inflammation and growth impairment
in children with CF. Whether this is a direct influence or indirectly through bacterial popula-
tion changes is unknown and will require further investigation. This could be one explanation
for why therapies directed at specifically modulating microbiota (e.g. probiotics [37]) may not
be sufficient. A holistic approach that incorporates other microbes (i.e. viruses) may be neces-
sary to restore intestinal homeostasis in children with CF.
The intestinal inflammation present in children with CF is clinically relevant given its nega-
tive correlation with growth (9). We have identified distinct mechanisms which may promote
intestinal inflammation in children with CF, including: (i) excess production of bacteriophage
endolysins (e.g. peptidoglycan-binding (PGRP) domain of peptidoglycan hydrolases) which
have potential pro inflammatory effects [19, 36], (ii) under expression of viruses which lyse
obligate intra-cellular parasitic bacteria (e.g. Gokushovirinae) [38] and bacteriophages associ-
ated with beneficial bacteria, Faecalibacterium prausnitzii (e.g. Faecalibacterium phage FP Tar-
anis) [39, 40], and (iii) over expression of bacteriophages associated with potentially
detrimental Proteobacteria (e.g. Podoviridae) [41]. Additionally, we identified several viruses
which positively (e.g. Anelloviridae and Enterovirus) and negatively (e.g. Protoparvovirus) cor-
related with growth measures in children with CF. Functional annotation of intestinal viruses
revealed distinct clusters between CF and HC when referencing the KEGG (Fig 4A and 4D)
and Pfam (based on relative abundance BC) databases (Fig 4C). A peptidoglycan-binding
(PGRP) domain of peptidoglycan hydrolases (COG3409) was significantly elevated in children
with CF compared to HC. These endolysins are synthesised by bacteriophages at the end of
their lytic cycle and result in the degradation of their host’s peptidoglycan-based cell wall to
allow for the release of viral progeny [36]. This finding may provide one hypothesis for the
reduced bacterial richness and Shannon index previously reported in CF children [4, 6]. Fur-
thermore, lysis of bacteria may release nucleic acids, proteins and lipids that serve as inflam-
matory response triggers, inducing cellular infiltration, cytokine production and even tissue
damage [19], a possible contributory factor to the elevated M2-PK in children with CF.
Consistent with current literature [16–19], intestinal viruses were predominantly bacterio-
phages, namely dsDNA Caudovirales and ssDNA Microviridae. Gokushovirinae were signifi-
cantly decreased in children with CF. Gokushovirinae are generally considered lytic viruses
and typically infect obligate intra-cellular parasitic bacteria, e.g. Chlamydia and Spiroplasma
[38]. Furthermore, Gokushovirinae peptidases resemble peptidases from Firmicutes (e.g. Fae-
calibacterium) and Proteobacteria (e.g. Ahrensia, Providencia) suggesting a horizontal acquisi-
tion of genes during a co-infection or infection of the prophage-bearing host cell [42]. The
importance of ssDNA viruses in CF intestinal dysbiosis, which were predominantly Gokusho-
virinae in our cohort, are further emphasised by the negative correlation with M2-PK. M2-PK
is expressed by rapidly proliferating intestinal cells and elevated in the setting of intestinal
inflammation and colorectal cancer [43], however the mechanism for a negative correlation
with ssDNA viruses is unclear. The decreased relative abundance of Gokushovirinae in our CF
cohort is also consistent with the reduction of capsid protein (F protein), which is a major cap-
sid component of ssDNA bacteriophages [36].
The relevance of intestinal viruses and inflammation is highlighted by Faecalibacterium
phage FP Taranis, which was significantly decreased in children with CF. The bacterial host
for this phage is F. prausnitzii [39], which has previously been reported to be decreased in chil-
dren and adolescence with CF [44], as well as in other inflammatory conditions including
inflammatory bowel disease and psoriasis [45]. F. prausnitzii is considered a beneficial bacteria
as it is an important butyrate producer with anti-inflammatory activity through the production
of MAM protein [40]. Therefore, reduced Faecalibacterium phage FP Taranis may be reflective
of reduced F. prausnitzii and reduced anti-inflammatory capacity i.e. resulting in elevated
PLOS ONE The intestinal virome in children with cystic fibrosis and controls
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inflammatory biomarkers (calprotectin and M2-PK) in children with CF. Additionally, Podo-
viridae (a family of dsDNA viruses) positively correlated with M2-PK and several phage from
this family are associated with potentially detrimental Proteobacteria (Enterobacteria, Escheri-
chia, Pseudomonas and Salmonella Phage) [41].
The associations between intestinal viruses and anthropometrics in children with CF
require further exploration as the potential mechanisms are unclear. We identified that in chil-
dren with CF, the family Anelloviridae and the genus Enterovirus positively correlated with
weight and BMI z-scores (S1 Table). A phage lysin, N-acetylmuramoyl-L-alanine amidase
(K01447) also positively correlated with height z-scores in children with CF (S2 Table). Proto-
parvovirus negatively correlated with weight z-scores and the only identified species of this
genus was PPV. Porcine parvovirus is currently not thought to infect humans [46] and the
negative correlation of Protoparvovirus with weight is more than likely reflective of an increase
in PERT dosing to improve weight gain in our CF clinic. The presence of the ssDNA viruses
PPV and PCV2 only in CF subjects may have unintentionally provided quality assurance of
our workflow, given that they are both known to be in porcine-derived PERT products pre-
scribed to patients with CF [31, 32]. Porcine circovirus 2 is ubiquitous among swine popula-
tions and not thought to infect immunocompetent humans [47].
The trends in alpha diversity indices between CF and HC cohorts with advancing age
appeared divergent (Fig 1C and 1D) and there was a significant difference in viral communi-
ties across ages in all children. Additionally, children with CF clustered separately from HC
(Fig 2B), despite the high degree of inter-individual variability (Fig 2A and 2B). These findings
highlight the need to further explore and/or control for age in future studies.
Our study is limited by the developing nature of virus reference databases. Unknown
viruses may influence our estimates of alpha and beta diversity. Our sequencing effort
appeared adequate for individual samples (saturation of rarefaction curves S1C and S1D Fig),
and similar to Shkoporov et al. (2019) [48], with 75% of reads mapped to viruses. A larger sam-
ple size is required for future studies to account for the high degree of inter-individual variabil-
ity in the intestinal virobiota, to get a complete picture of the virome of CF patients, and
minimise the influence of outliers (which is controlled for using the ANCOM analysis [49]).
Although the percentage of predictions mapped to functional terms is small, a recent review of
human gut virome literature identified 18 studies, none of which performed a functional anno-
tation [50]. Bacterial contamination rates in our sequencing data were quite varied and could
require optimisation, however the level is on par with other current studies [27, 28]. Bacterial
community data (i.e. 16S rRNA sequencing data) was only available for two CF and five HC
participants, therefore we were unable to assess the relationships between intestinal bacteria
and viruses. Paired 16S rRNA and viral sequencing data would likely provide important
insights into bacteriophage-host relationships. Given our study only investigated children
aged 3 to 12 years, further studies on infants, young children and adolescents are warranted,
particularly in light of the age-related differences. Additionally, potential confounding factors,
including antibiotic usage and altered dietary regimens between CF and HC were not con-
trolled for with this study. Future longitudinal studies across a wider age range with a multi-
omics approach will likely provide greater insights including phage-host associations, patient
immune response effects and potentially unravel therapeutic targets in CF gastrointestinal dis-
ease. Mechanisms promoting intestinal inflammation in children with CF also warrant further
investigation, particularly the excess production of bacteriophage endolysins and their down-
stream effects. Future in-vitro studies using CF-intestinal epithelial cell lines or patient derived
models with intestinal organoids should be considered for future research.
In conclusion, there exists an altered intestinal virome in children with CF compared with
HC, which provides novel insights into paediatric CF gastrointestinal disease. Faecalibacterium
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phage, Gokushovirinae and phage lysins are considerations for future areas of research, specifi-
cally in the context of intestinal inflammation in CF. A high degree of inter-individual varia-
tion in the intestinal virome, which changes across age, suggests that larger, longitudinal
studies are warranted. Intestinal viruses and their functions may have important clinical impli-




We performed a prospective, cross-sectional, case-control study in children with CF and HC.
The subjects and samples for this analysis were collected as part of three prior studies evaluat-
ing the progression of intestinal microbiota and inflammation in children with CF [4, 7, 11].
Children with CF and HC were prospectively recruited from the outpatient clinics (CF and
Orthopaedic/Plastics clinics respectively) at Sydney Children’s Hospital Randwick, Australia.
Children with CF were matched to HC for gender and age (as closely as possible). We included
children: (i) aged 0 to 18 years; (ii) with CF diagnosed according to the United States Cystic
Fibrosis Foundation consensus criteria [51]; (iii) exocrine pancreatic insufficiency based on
the 72-hour faecal fat and/or faecal elastase-1 [52, 53]; (iv) as healthy controls if they did not
have CF or any gastrointestinal disease. We excluded children: (i) requiring antibiotic therapy
for a pulmonary exacerbation [54] or intravenous antibiotics in the preceding four weeks
before sampling; (ii) with gastroenteritis, on oral corticosteroids, probiotics and/or non-steroi-
dal anti-inflammatory drugs in the preceding two weeks before sampling. We did not exclude
children with CF on prophylactic oral or inhaled antibiotic therapy.
This study was approved by the South Eastern Sydney Area Health Service, Human
Research Ethics Committee, Sydney Australia (HREC/10/240). Written informed consent was
obtained from each subject or caregiver(s) and the study was carried out in accordance with
the approved guidelines.
Sample and data collection
Stool samples were collected to provide a non-invasive representation of the intestinal viral
communities and environment. Specifically, stool samples reflect the luminal contents of the
large intestine, however for the purpose of this manuscript, will be referred to as a representa-
tion of the intestine. A single stool sample from each subject was collected and stored immedi-
ately at –80˚C, or stored at –20˚C (home freezer) until transport to the laboratory for storage
at –80˚C. Thawing of the sample during transport did not occur. At the time of sample collec-
tion, demographic and anthropometric data (height, weight and BMI z-scores) was recorded.
Virome pipeline
Sample preparation to enrich for faecal viruses followed an adjusted NetoVIR (Novel Enrich-
ment Technique Of VIRomes) protocol [55]. Details are provided in S1 Methods. Briefly, sam-
ple processing involved: (i) stool being suspended in sterile phosphate-buffered solution,
homogenised and centrifuged at 17,000g (ii) supernatant being filtered through a 0.8 μm PES
centrifugal filter; (iii) filtered supernatant being treated with nuclease buffer and micrococcal
nuclease; (iv) viral nucleic acids being extracted using the QIAamp Viral RNA Mini Kit (Qia-
gen) according to manufacturer’s instructions for the extraction of viral RNA and DNA, with
the exception of centrifugation speed lowered from 20,000 × g to 17,000 × g; (v) nucleic acids
being eluted to RNA storage solution (Ambion) and storage at -80˚C; (vi) random
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amplification of nucleic acids using the Whole Transcriptome Amplification Kit 2 according
to the manufacturer’s instructions (Sigma Aldrich); (vii) amplified products being purified
using the Wizard1 PCR Cleanup Kit (Promega); and (viii) library preparation using the Nex-
tera XT kit and a repeat purification step. A DNA size selection step was omitted before
sequencing as both solid phase reversible immobilisation beads and manual excision from aga-
rose gel did not achieve desired results. Samples were sequenced using the Illumina MiSeq 500
platform (2 × 150bp).
Taxonomic assignment of virome reads was performed using the Vipie platform [56].
Paired-end sequences were uploaded (https://binf.uta.fi/vipie/) using the default parameters
with the exception of: (i) read length of 150 base pairs; (ii) subsample of 0.80; (iii) Kmer length
of 31; (iv) remapping of hits PER 1,000,000 and (v) minimum total matches of 2. Further
details are provided in S2 Methods. The output included a search hit table of all viruses for
each sample, which were combined for further analyses.
Functional annotation was performed using the Virsorter pipeline [33] to generate predic-
tions which were searched against the KEGG (34), COG (35) and Pfam [36] databases.
Inflammatory biomarkers
Calprotectin was extracted and measured as described in a previous study [7] using the PhiCal
kit (Calpro, San Diego, CA, US). The lower limit of detection for the assay was 19.5 mg/kg.
Calprotectin > 50 mg/kg is considered elevated. Faecal M2-PK was extracted and measured as
described in a previous study [11] using the ScheBo Tumour M2-PK kit (ScheBo Biotech,
Giessen, Germany). The lower limit of detection of the assay was 1 U/mL.
Statistical analysis
Statistical analysis was performed in R v3.4.4. Alpha diversity indices (richness and Shannon
index) were calculated. For viral taxa, relative abundance was calculated as the proportion of
all contigs taxonomically assigned. For functions, relative abundance was calculated as the pro-
portion of all assigned predictions. Bray-Curtis dissimilarities based on relative abundance
and presence-absence data were calculated using the vegan package [57] and used to generate
non-metric multidimensional scaling (NMDS) plots. Permutational multivariate analysis of
variance (PERMANOVA) tests (permutations = 1000) were utilised to test if beta diversity sig-
nificantly differed among groups (‘CF vs HC’ and ‘male vs female’) and age using the vegan
function adonis [57]. A significant difference in abundance of viruses or protein functions
between CF and HC groups was assessed using the ANCOM package v1.1–3, which uses non-
parametric Kruskal-Wallis tests (Benjamini & Hochberg correction for multiple comparisons,
q<0.05) [49]. Continuous variables were compared using a t-test or Wilcoxon signed-rank test
for parametric and non-parametric data, respectively (p<0.05 considered statistically signifi-
cant). Generalised linear models (glm function; using a Gaussian distribution) were con-
structed to control for age when comparing continuous variables between cohorts.
Correlations between continuous variables were assessed using Spearman correlations (Benja-
mini & Hochberg correction, q<0.05) [58]. Graphs were generated using ggplot2 in R [59].
Supporting information
S1 Fig. Rarefaction curves for CF and HC cohorts. The number of viruses given the number
of samples (A & B) and the number of viral sequences per stool sample (C & D).
(TIFF)
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S2 Fig. (A-E) Relative abundance of all viruses at each taxonomic rank: (A) group; (B) order;
(C) family (top 20 most abundant); (D) genus (top 20 most abundant); (E) species (top 20
most abundant). CF and HC subjects ordered in increasing age (from left to right).
(TIF)
S3 Fig. Viruses with a significantly different abundance between CF and HC cohorts (at
each taxonomic rank) using ANCOM analysis (q<0.05). (A) Myoviridae was present in 6/8
(75%) CF and 7/8 (87.5%) HC samples. (B) Unclassified Gokushovirinae was present in 4/8
(50%) CF and 8/8 (100%) HC samples. (C) Faecalibacterium phage FP Taranis was not present
in CF samples (0%), however, was present in 6/8 (75%) HC samples. No statistically significant
differences (q<0.05) were identified at the group and order ranks.
(PDF)
S4 Fig. COG (A) and Pfam (B) terms with a significantly different abundance between CF
and HC cohorts using ANCOM analysis (q<0.05). KEGG (C) terms with a different abun-
dance between CF and HC cohorts which was close to significance (q<0.1). COG3409, pepti-
doglycan-binding (PGRP) domain of peptidoglycan hydrolases; K08640, zinc D-Ala-D-Ala
carboxypeptidase; PF02305.16, capsid protein (F protein).
(PDF)
S5 Fig. Scatterplots of the relative abundance of: (A-C) viruses (family, genus, species); (D) a
COG terms, (E) a Pfam terms, and (F) a KEGG term, against age in CF and HC cohorts.
Cohort mean and 95% confidence intervals are constructed from generalised linear models
and presented as lines and shaded regions, respectively.
(TIFF)
S6 Fig. Faecal inflammatory biomarkers. Calprotectin (A) was significantly elevated in chil-
dren with CF compared to HC (98.9 mg/kg (50.1–104.9) vs. 19.5 mg/kg (19.5–30.5), respec-
tively, p = 0.047). M2-PK (B) was significantly elevated in children with CF compared to HC
(7.4 U/ml (6.3–22.6) vs. 1.0 U/ml (1.0–1.0), respectively, p = 0.005).
(TIFF)
S1 Table. Correlations between the relative abundances of viruses and: (i) anthropometric
z-scores, and (ii) inflammatory markers in children with CF. �Spearman correlations
(q<0.05) considered statistically significant, with the remaining Spearman correlations
(q<0.1) considered close to significance. Analysed virus highlighted in bold, and multiple
bold viruses in a single row indicates consistent results across taxonomic ranks. Calpro, cal-
protectin.
(DOCX)
S2 Table. Correlations between the relative abundances of KEGG, COG and Pfam terms
with: (i) anthropometric z-scores, and (ii) inflammatory markers in children with CF.
�Spearman correlations (q<0.05) considered statistically significant, with the remaining Spear-
man correlations (q<0.1) considered close to significance.
(DOCX)
S1 Methods. Sample processing for viral metagenomics.
(DOCX)
S2 Methods. Vipie platform (56) analysis parameters.
(DOCX)
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S1 Data. Meta data: Demographic, clinical and inflammatory biomarker data.
(CSV)
S2 Data. Sequence characteristics: Read counts, de novo assembly and distribution of all
reads.
(CSV)
S3 Data. Virome table: The abundance of viruses identified in each sample.
(CSV)
S4 Data. Functional annotation: Results of viral contigs which were searched against
KEGG, COG and Pfam databases.
(CSV)
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